GlassScriptPhysician profile
Weizhen Xu
NPI 1881787604
$1,136.20
in general payments reported to CMS, 2019-2025
20 companies · $70.16 in 2025
The $70.16 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $245 · 2022: $265 · 2023: $31.43 · 2024: $84.31 · 2025: $70.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $394.97 | 2019-2025 | Sogroya |
| Abbvie INC. | $138.98 | 2019-2024 | Lupron Depot |
| Janssen Pharmaceuticals, INC | $111.43 | 2020 | |
| Rhythm Pharmaceuticals, INC. | $101.30 | 2022 | |
| Insulet Corporation | $78.64 | 2019-2025 | Omnipod |
| Dexcom, INC. | $34.34 | 2019 | |
| Arbor Pharmaceuticals, INC. | $33.61 | 2019 | |
| Tandem Diabetes Care, INC. | $31.60 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $28.17 | 2019 | |
| Alexion Pharmaceuticals, INC. | $27.66 | 2019-2020 | |
| Abbott Laboratories | $22.77 | 2020 | |
| Medtronic, INC. | $17.10 | 2024 | Minimed 780g |
| Tolmar, INC. | $15.94 | 2024 | |
| Sanofi-Aventis U.S. LLC | $15.68 | 2023 | |
| Senseonics, Incorporated | $15.00 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $15.00 | 2019 | |
| Pfizer INC. | $14.85 | 2019 | |
| Endo Pharmaceuticals INC. | $13.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.21 | 2019 | |
| Sandoz INC. | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weizhen Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.